1,888 Shares in Zoetis Inc. (NYSE:ZTS) Acquired by Wealthcare Capital Partners LLC

Wealthcare Capital Partners LLC bought a new position in Zoetis Inc. (NYSE:ZTS) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 1,888 shares of the company’s stock, valued at approximately $308,000.

A number of other institutional investors also recently bought and sold shares of ZTS. Mizuho Securities USA LLC raised its position in Zoetis by 13,726.9% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock worth $950,524,000 after buying an additional 4,829,815 shares during the last quarter. International Assets Investment Management LLC raised its position in Zoetis by 41,235.7% during the 3rd quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock worth $183,652,000 after buying an additional 937,700 shares during the last quarter. Assenagon Asset Management S.A. raised its position in Zoetis by 296.9% during the 4th quarter. Assenagon Asset Management S.A. now owns 889,444 shares of the company’s stock worth $144,917,000 after buying an additional 665,331 shares during the last quarter. Nordea Investment Management AB raised its position in Zoetis by 38.3% during the 4th quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock worth $336,266,000 after buying an additional 572,511 shares during the last quarter. Finally, Holocene Advisors LP purchased a new position in Zoetis during the 3rd quarter worth approximately $110,809,000. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Trading Up 0.2 %

Shares of ZTS opened at $171.71 on Tuesday. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The firm’s fifty day moving average is $169.26 and its two-hundred day moving average is $179.21. The stock has a market cap of $77.47 billion, a PE ratio of 32.28, a price-to-earnings-growth ratio of 2.77 and a beta of 0.90.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.16%. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Leerink Partners assumed coverage on shares of Zoetis in a report on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price for the company. Stifel Nicolaus cut their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Leerink Partnrs raised shares of Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Morgan Stanley cut their target price on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a report on Wednesday, January 29th. Finally, UBS Group assumed coverage on shares of Zoetis in a report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price for the company. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $214.00.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.